Anti VEGF for post op CME- Boon or Bane!

Autor:	Roshni Mohan, M Arthi, S Balamurugan
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	anti-vascular endothelial growth factor bevacizumab corticosteroids cystoid macular edema phacoemulsification Ophthalmology RE1-994
Zdroj:	TNOA Journal of Ophthalmic Science and Research, Vol 60, Iss 1, Pp 71-73 (2022)
Druh dokumentu:	article
ISSN:	2589-4528 2589-4536
DOI:	10.4103/tjosr.tjosr_127_21
Popis:	Cataract surgery has advanced in techniques and instrumentation over the years, but complications such as cystoid macular edema (CME) do occur even after uneventful surgery. The incidence of pseudophakic CME (detected by optical coherence tomography) is 30%–40% after uncomplicated phaco cataract surgeries. Risk factors for the development of CME include prolonged duration of surgery, iris handling and diabetes. Corticosteroids are the mainstay of treatment of postoperative inflammation and CME. In certain situations where steroids are contraindicated anti-vascular endothelial growth factor (VEGF) agents are used as the second line agents for the treatment of CME. Here, we describe a case of postoperative uveitis with CME which showed good response with single dose intravitreal anti-VEGF injection-Bevacizumab.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/beb93b7128854fdaa5dbdf10c4db87cd Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.